Need professional-grade analysis? Visit stockanalysis.com
$40.07M
25.85
N/A
N/A
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.92, down 0.04% from the previous close.
Over the past year, ZYBT has traded between a low of $0.71 and a high of $14.15. The stock has lost 91.3% over this period. It is currently 93.5% below its 52-week high.
Zhengye Biotechnology Holding Limited Ordinary Shares has a market capitalization of $40.07M, with a price-to-earnings ratio of 25.85.
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Side-by-side comparison against top Healthcare peers.